HIV Thrive

Living Well With HIV

[American Academy of HIV Medicine @aahivmcomm]

Today is National Black HIV/AIDS Awareness Day, a day to acknowledge progress in HIV prevention and care among Black/African American people, while recognizing the work still needed. To #StopHIVTogether, we must address HIV stigma and barriers. https://t.co/xBZAg1toI8 #NBHAAD

[HIV Thrive @hivthrive]

How the monkeypox outbreak revealed the path for vanquishing viruses https://t.co/T0XXh6gJa1

[American Academy of HIV Medicine @aahivmcomm]

#EHE Initiative funded community health centers were able to provide PrEP to over 50,000 people in 2020 despite COVID-19 disruptions according to a HRSA report. This program works and needs to be adequately funded! See our recommended funding levels. https://t.co/JsfDGdWu6N

[Avita Pharmacy @AvitaPharmacy]

Is your #pharmacist playing a key role in your health care journey? Here’s why they should be. https://t.co/zPKWmPRIsn

[Avita Pharmacy @AvitaPharmacy]

Win-win: More than $20 million will go to community health centers in the fight to #EndHIV. https://t.co/Lt2F54GtaB

[[email protected] 🏳️‍⚧️💊🏳️‍🌈 @jay_pharm]

This is amazing news! However, as healthcare providers we also have a responsibility to make sure we are both competent and our health system infrastructure is trans-affirming. We can do this, we can answer the call! #TwitteRx @MichRxConsult @CAPharm

[MichRx Consulting- ConsciousPharmacistPodcast @MichRxConsult]

⁦@AvitaPharmacy⁩ ⁦@PharmacyPodcast⁩ ⁦@radianthealthoc⁩ ⁦@CAPharm⁩ ⁦@pharmacists⁩ ⁦@OCPhA_CA⁩ #pharmacists #pharmacistprovider #consiouspharmacistpodcast #sexualhealth https://t.co/nIwkJ2LwXE

[HIV Thrive @hivthrive]

PrEP Implementation Does Not Lead to Increases in STIs - Infectious Disease Special Edition https://t.co/wZYyRcyP7J

[Avita Pharmacy @AvitaPharmacy]

“Gone are the days when the pharmacist is standing behind the counter counting pills.” Internationally recognized HIV pharmacist Michelle Sherman explains why pharmacists are crucial to a patient’s overall health care journey. https://t.co/yILhwjUBnv

[Avita Pharmacy @AvitaPharmacy]

Compassion is key when it comes to self-care. For people living with #HIV or mental health struggles, that can be tough—but not impossible. Here’s how to give yourself some grace. https://t.co/Ngroawxp0v

[HIV Thrive @hivthrive]

FDA Authorizes Intradermal Use of Jynneos Vaccine for Monkeypox https://t.co/PrdrX3wXKQ

[IAC - the International AIDS Conference @AIDS_conference]

The negative impact of #COVID19 on the #HIV response included reductions in ART initiations, reductions in harm reduction services, and reduced access to #TB diagnosis and treatment, resulting in more TB deaths among people living with HIV.” - Anthony S. Fauci 🇺🇸 #AIDS2022

[Pharmacy Podcast Network @PharmacyPodcast]

Supporting LGBTQ #Pharmacists & #Pharmacy Students w/ Dr. Jay Holloway @jay_pharm PharmD & Dr. Ken O'Shea PharmD @dr_o_slayyy

Shining visibility on Trans pharmacy students and pharmacists.

Thank you @MichRxConsult for this wonderful conversation.

https://t.co/aCm4IzpsMe

[Radiant Health Centers @radianthealthoc]

Anyone can get #Monkeypox & the CDC is working to provide more info to a wider audience about symptoms & the behaviors that can lead to the spread of Monkeypox.

The #OCHCA is holding a Monkeypox vaccine clinic by appt only. To learn more visit https://t.co/5xFXHZQjP5.

[IAS - the International AIDS Society @iasociety]

Hasina Subedar 🇿🇦 reflects on DSD for PrEP in #SouthAfrica at #AIDS2022:

"With HIV self-testing, more PrEP users can manage themselves. And now in South Africa, after one month on PrEP, PrEP users are eligible for three-monthly PrEP refills and this is a game changer for us."

[IAC - the International AIDS Conference @AIDS_conference]

The words we use matter in the response to #HIV. #AIDS2022

[Prevention Access @PreventionAC]

Mandisa Dukashe (South Africa) shares her experience of disclosure to her husband and being able to conceive without fear of transmission to her husband, and being able to love without fear!

#UequalsU #AIDS2022

[HPTN @HIVptn]

HPTN at #AIDS2022: Dr. Sinead Delany-Moretlwe presents updated efficacy and safety results from HPTN 084: Long-Acting #Cabotegravir for #HIVprevention in cisgender women.

❗️TODAY | 11:45 ET | Room 220 | Channel 1❗️

https://t.co/DY6WwHIp61